The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its molecular structure, don’t typically interact with many chemicals.

A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ability to mitigate brain damage and improve cognitive functions in mouse models.

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped reduce levels of brain atrophy and neuroinflammation.

Researchers from Mass General Brigham and Washington University have found that Xenon gas inhalation reduces neuroinflammation, brain atrophy and amyloid and tau pathologies in Alzheimer’s mouse models.

Scientists have discovered that inhaling xenon gas can activate brain immune cells to break down Alzheimer's-related plaques and reduce inflammation. Successful mouse experiments are paving the way for human trials.

Breathe easy — researchers say they may have found an innovative approach to treating Alzheimer’s disease. There is no cure for the brain disorder, which affects more than 6 million Americans. Treatment progress has been slow because scientists don’t fully understand what causes the complex disease.